1. 2-(Benzhydryl sulfinyl)-N-sec-butylacetamide) isolated from fig augmented trastuzumab-triggered phagocytic killing of cancer cells through interface with Fcγ receptor
- Author
-
Eman T. Ali, H. N. K. Al-Salman, Khetam H. Rasool, Majid S. Jabir, Tirth R. Ghimire, Falah H. Shari, Hussein H. Hussein, Adil A. Al-Fregi, Ghassan M. Sulaiman, Khalil A. A. Khalil, Elsadig M. Ahmed, and Mohamed T. A. Soliman
- Subjects
Organic Chemistry ,Plant Science ,Biochemistry ,Analytical Chemistry - Abstract
The objective of the current study was to extract 2-(benzhydryl sulfinyl)-N-sec-butylacetamide), a novel compound from fig, and then determine its role in enhancing trastuzumab-triggered phagocytic killing of SKOV-3 cancer cells. In this study, Soxhlet was used to extract the compound from the mature and air-dried fig fruits. The production of the isolated extracts was enhanced by using polar and non-polar solvents. Several solvents, such as methanol, ethyl acetate, chloroform, and n-hexane, were used to isolate the effective compound 2-(benzhydryl sulfinyl)-N-sec-butylacetamide) from the organic layer. UV-spectroscopy, FT-IR, 1H-NMR, and 13C-NMR were applied to identify the purified compound. The in vitro and in vivo assays demonstrated that the 2-(benzhydryl sulfinyl)-N-sec-butylacetamide) can increase the activity of the phagocytic cells, via the interaction with FcY receptors, along with trastuzumab, and the pathway can use a model for the therapeutic strategy for effective treatment of ovarian cancer cells.
- Published
- 2023
- Full Text
- View/download PDF